Vaso-occlusion, the stoppage of blood flow in sickle-cell disease, is a complex dynamical process spanning multiple time and length scales. Motivated by recent ex vivo microfluidic measurements of hemostasis using blood from sickle-cell patients, we develop a multiphase model that couples the kinetics and hydrodynamics of a flowing suspension of normal and sickled cells in a fluid. We use the model to derive expressions for the cell velocities and concentrations that quantify the hydrodynamics of hemostasis, and provide simple criteria as well as a phase diagram for occlusion, consistent with our simulations and earlier observations.
Sickle-cell disease (SCD) was the first genetic disease to be linked to the mutation of a specific protein [1] . The disease is caused by a point mutation in the molecule hemoglobin, the active constituent of red blood cells (RBCs) that transports oxygen from the lungs to the rest of the body. Unlike the normal protein, hemoglobin A (HbA), the mutant protein, hemoglobin S (HbS), polymerizes to form filaments [2] [3] [4] under deoxygenated conditions typical of the venous system, a process that is reversible upon oxygenation in the lungs. The resulting HbS polymers alter the rigidity of RBCs and can lead to the characteristic sickled cell shape associated with the disease [5, 6] . The stiffer RBCs slow down in the venous system where further oxygen starvation exacerbates the effect, eventually leading to vaso-occlusion, clogging, and hemostasis resulting in a crisis [7] .
The events that lead to vaso-occlusion span multiple time and length scales [8, 9] , from Oð10 À1 sÞ to Oð10 3 sÞ for the kinetics of HbS polymerization to the hydrodynamics of blood flow, and from Oð10 À9 mÞ to Oð10 À5 mÞ for the size of the protein to the dimensions of the circulatory vessels. In addition, the positive feedback between cell sickling and fluid flow makes the process both nonlinear and stochastic. While extensive work has been carried out to probe the individual determinants of SCD [5, [10] [11] [12] [13] , integrating across these in order to provide quantitative insights into the overall dynamics of jamming in SCD remains a challenge. Here, we develop a minimal framework that attempts to capture the salient features of occlusion dynamics in terms of the chemical and physical processes at hand.
Recent studies of vaso-occlusion in SCD ex vivo [9, 14] capture the pathophysiology of this molecular disease while providing a simple biophysical assay for its likelihood. In these experiments, whole blood from patients is flowed through a microfluidic channel adjacent to a gas reservoir with permeable walls. Rapid deoxygenation (oxygenation) of the channel driven by the gas reservoir leads to occlusion (rescue). Figure 1 shows a sample of the dynamics of occlusion obtained as consecutive video frames [14] at the beginning [free flow, Fig. 1(a) ] and end [occluded, Fig. 1(b) ] of the process. We see that occlusion corresponds to the transition from the unimpeded flow of a soft suspension of cells which move relative to one another [ Fig. 1(a) ] to the formation of a porous plug of cells through which plasma may continue to flow [ Fig. 1(b) ].
To understand this, we consider the flow of blood, initially containing plasma and unsickled cells, through a capillary channel. The entire channel is rapidly and homogeneously deoxygenated at time t ¼ 0 and maintained in this state [14] , with plasma and unsickled cells continuing to flow in from the boundary at x ¼ 0, Fig. 1(c) . As in the experiments [9, 14] , we assume a constant pressure drop over the deoxygenated channel through the entire process. To quantify the dynamics of occlusion, we choose to describe this system in terms of the flow of a multiphase fluid where the volume fractions of plasma, sickled RBCs and unsickled RBCs are denoted as ðt; xÞ, þ ðt; xÞ, and À ðt; xÞ, respectively, with þ þ þ À ¼ 1. The evolution of these fractions is described by fluid mass conservation, and the advection and the conversion of unsickled to sickled cells: @ =@t þ r Á ðu Þ ¼ 0, @ AE =@t þ r Á ðu AE AE Þ ¼ AE À = K , where the sickling is assumed to follow first-order kinetics with a characteristic kinetic time K [5, 8, 15, 16] . Since RBCs are 4 m in radius, their equilibrium diffusivity is negligible, but their nonequilibrium effective hydrodynamic diffusivity is nonzero [17] ; here we neglect this effect, focusing on a mean-field theory.
When few cells have sickled [ Fig. 1(a) ], the plasma and RBCs flow freely and we may describe the velocity of the plasma u and the cells u AE ( ¼ u þ ¼ u À , assuming that the sickled and unsickled cells move at the same velocity) effectively using the Stokes approximation: rp $ 0 r 2 u with u AE ¼ u , and 0 being an effective
week ending 29 MARCH 2013 suspension viscosity. As further cells sickle, the relatively unimpeded flow of the cells and plasma progressively transforms as the cells form a slowly moving porous plug through which the plasma continues to flow. This leads to a flow regime better described by the Darcy approximation for flow through porous media: rp $ 0 ðu À u AE Þ= 0 , where 0 is the hydraulic permeability of the porous plug. Exploiting the linearity of the equations describing the two limits, we interpolate the transition from Stokes flow to Darcy flow by using the momentum balance equations of the form rp ¼ 0 fr 2 u À ðu À u AE Þ= 0 g; this form is similar to the Darcy-Brinkman equation [18] . To complete the formulation of the problem, we require a relationship between the plasma and cell velocities. At the cellular scale, the stiffening of RBCs due to intracellular HbS aggregation causes an increase in the strength and frequency of interactions with the vessel walls and with other cells [19, 20] . The cell velocity starts to progressively differ from that of the plasma, and eventually, when a critical volume fraction of cells have sickled, the cell velocity falls to zero resulting in vaso-occlusion [ Fig. 1(b) ]. Neglecting the role of inertia, we describe the collective slowing down of the cells, due to their increasingly frequent interactions, using the local power-law relationship u À u AE ¼ ð þ = Ã Þ u , where Ã is the critical volume fraction of sickled cells at jamming, and 0 =ð þ = Ã Þ is the effective permeability of the cells. This form recovers the two limits u AE ¼ u when þ ¼ 0, i.e., there are no sickled cells, and u AE ¼ 0 when þ ¼ Ã , i.e., at occlusion; the exponent controls the sharpness of the transition.
For flow through a high-aspect ratio channel, Fig. 1 (c), of length L and height R with an initial cell fraction (hematocrit) 0 À [ % 0:25 in Fig. 1(a) ], we define the dimensionless quantities (indicated using tildes) via:
with the pressure difference p 0 , and x ¼ x 0x with x 0 ¼ R. Dropping the tildes from here on leads to the dimensionless equations
(1)
for the variables , þ , À , u þ , u À , u , p where the aspect ratio À1 : ¼ L=R ) 1 and we identify H = K as the dimensionless ratio of a hydrodynamic time for transit through the capillary to a kinetic time for cell sickling, and : ¼ Ã ð 0 =R 2 Þ 1= < Ã as a characteristic scaled volume fraction of sickled cells given by the ratio of the jamming fraction Ã and the dimensionless permeability.
Interestingly, although the critical fraction Ã defines the fraction of sickle cells at a blockage, the crossover in the rheology associated with the Stokes-Darcy transition according to (4) occurs at a lower crossover sickle-cell fraction þ $ , when the cells are still mobile. As the sickle-cell fraction increases, positive feedback associated with the increased resistance to flow for a given pressure drop provides additional time for the fraction of sickled cells to increase, and the cell and plasma velocities deviate more and more according to (5) . Eventually, the fluid velocity u ! À8 À1 ð 0 =R 2 Þ 1= rp from (4), and occlusion occurs as þ ! Ã .
To build on this qualitative picture, we now analyze solutions to (1)-(5) computed for 2D flow using the COMSOL finite element package [21] and provide simple analytical estimates that help us to understand the various flow regimes.
No occlusion.-When few cells sickle during transit, the plasma and cell velocities remain approximately unchanged relative to those of the original Stokes flow, u S : ¼ ðu S ; 0Þ, and occlusion does not occur. The channel residence time t o for a fluid-cell parcel is approximately t o ¼ xu À1
S for parcels that have flowed in at t > 0, and t o ¼ t for parcels that occupied the channel at t ¼ 0 but have yet to exit. Therefore, the sickle-cell fraction, which evolves through first-order kinetics, is þ ¼ 0 À ½1 À expð À minðt; xu À1 S Þ H = K Þ, as shown in Fig. 2 and video 1 in the Supplemental Material [22] , and compared to numerical solutions to (1)-(5). Since the velocity u S remains constant in time, the second term in the minimum operator is the smallest for t ) u À1 S , implying that cells initially at the inlet have exited the channel, leading to the steady-state profile þ ¼ 0 À ½1 À expðÀxu À1 S H = K Þ. Thus, although there is progressive sickling along the microchannel, too few cells sickle before reaching the outlet to effect significantly the bulk rheology of the suspension.
Occlusion.
-If the sickle-cell fraction increases sufficiently, however, the cell and plasma velocities progressively deviate from those of the original flow profile. The channel residence time for a fluid-cell parcel is the sum of times taken to traverse each distance ds, t o ¼ minðt; x R x 0 u AE ðtðsÞ; sÞ À1 ds=xÞ minðt; x u À1 Þ, yielding
where u is an average longitudinal velocity for each parcel bounded by its initial and current velocities. The transition from nonocclusive to occlusive flow is shown in Fig. 3 and video 2 in the Supplemental Material [22] . In a Lagrangian framework, we see that cells starting at the inlet move initially at an unperturbed velocity u AE % u S ( u % u S ) as they sickle [ Figs. 2(a) and 3(a) ]. In the nonocclusive case, they reach the outlet with the steady state concentration profile [ Fig. 2(a) ]. In contrast, if the sickle-cell fraction reaches þ $ during transit [ Fig. 3(b) ], the cell velocity u AE (and u) decreases [ Fig. 3(d) ] and the sicklecell fraction increases [ Fig. 3(c) ] until the channel gets blocked. In contrast to nonocclusive dynamics, the first term in the minimum operator in (6) dominates for long times, implying that cells initially at the inlet never exit the channel, and the sickle-cell fraction increases to Ã with a concomitant occlusion.
Away from the inlet to the channel, (6) reduces to
For the high aspect ratio capillary, where @ 2 u=@x 2 ( @u 2 =@y 2 and the longitudinal pressure gradient @p=@x % is relatively uniform with @p=@y % 0, substituting the approximate velocity field u ¼ ðu ðyÞ; 0Þ into (4) yields @ 2 u =@y 2 À ð þ = Þ u ¼ À8, subject to the boundary conditions u ðAE1=2Þ ¼ 0. This system has the solution
for the plasma velocity in terms of the sickle-cell fraction, which together with (5) and (7) yields the cell velocity along the channel and compares well with results of numerical simulations of the full problem [ Fig. 3(d) ].
FIG. 3. Occlusive dynamics. (a)
Sickle-cell fraction for early times from t ¼ 0 to t ¼ 0:03 (light to dark gray) before þ reaches , analogous to nonocclusive flow from Fig. 2(a) . The position of the knee, initially x % u S t around which the x axis is zoomed, corresponds to that of a fluid-cell parcel which was at the inlet at t ¼ 0; in the occlusive case this parcel never reaches the outlet. The dashed lines are (6) (5), (7), and (8) . In (a)-(d), the solid lines are calculated numerically from (1)- (5) with the initial and boundary conditions from (5), with the initial and boundary conditions from Fig. 1(c) ; the dashed lines are the analytical solution (6) with (10) . See video 1 in the Supplemental Material [22] for the evolution throughout the channel.
Using 
with :
, and valid up to t < =, a characteristic time to occlusion. Here, is the product of two factors: the ratio of the kinetic time to the hydrodynamic time and the ratio of the crossover fraction of sickled cells to the initial hematocrit, while is the ratio of the crossover sickle fraction at the Stokes-Darcy transition to the critical fraction at occlusion, or equivalently the hydraulic permeability 0 scaled by the channel width R.
Decomposing the cell velocity (9) into the plasma velocity u ðtÞ and the differential velocity between the plasma and cells dðtÞ shows the crucial role of this cell-plasma differential velocity, driven by sickling. A comparison of our predictions with ex vivo experimental data for blood from a patient with severe SCD flowing through microchannels [14] is shown in Fig. 4(a) ; by fitting the parameters , in (9) we capture the experimentally observed flow deceleration curve until hemostasis. Figure 4 (b) shows a phase diagram for the dynamics of flow and stasis in SCD, characterized by the ratio of the kinetic to the hydrodynamic time scales and the scaled initial cell fraction. Vaso-occlusion occurs when the bulk cell velocity is zero, a condition satisfied when þ reaches in a time t&1, which implies H = K >Àlogð1À = 0 À Þ. For = 0 À < 1, expanding the logarithm to first order yields the simple criteria
which are intuitive: a small polymerization time scale K for sickling or a long hydrodynamic time scale H for traversing the microcirculation favors occlusion, as does a high hematocrit 0 À or a low crossover sickle fraction . Thus, while the time scale for occlusion is controlled by =, the condition for occlusion is controlled by .
Analysis of experimental data for flow deceleration, such as in Fig. 4(a) , for five patients [14, 23] suffering from severe SCD yields the ranges 0:10 < < 0:13 and 0:27 < < 0:39, consistent with the phase diagram Fig. 4 (b) and the criteria (10) . Since H % 320 s, 0 À % 0:3, and 0:3 < Ã < 1 for these experiments [14, 23] , these values of and imply K % 60 s, % 0:2 and an occlusive time scale of H = % 130 s, consistent with hydrodynamic experiments [9, 14] and in agreement with in vitro HbS polymerization kinetics [15, 16] .
Our work integrates the kinetics and hydrodynamics of capillary flow and hemostasis in SCD in terms of a minimal multiphase model with just two parameters, and , that quantify (i) the kinetic hypothesis in SCD [4, 5, 8, 9, 24, 25] , where vaso-occlusion is favored when the ratio of a characteristic time scale for cell sickling to that for the RBCs to traverse the microcirculation, K = H in (10), is small, and (ii) the characteristic concentrations of cells, i.e., the initial hematocrit, scaled by a crossover concentration = 0 À in the condition for occlusion (10) , and scaled by the critical sickle fraction Ã = 0 À in the occlusive time scale =. The results are summarized by the simple criteria (10) and the accompanying phase diagram Fig. 4(b) , both of which characterize occlusion.
Clinically, the primary determinant of disease severity in patients [5, 24] is likely to be the ratio K = H in , consistent with our recent study distinguishing patients with benign and severe symptoms [14] . In addition, the differences in the characteristic concentrations, particularly , might also contribute to the variations between patients with severe disease [14] . Going forward, it would be interesting to study the dissolution of jams upon reoxygenation when cells unsickle, and the observed hysteresis [9, 26] ; indeed, this follows from our model when the reaction term in (2) is reversed to read Ç þ H = U , where U < K [9] is the characteristic time for cells to unsickle. Our theory does not account for fluctuations; accounting for these via the incorporation of nonequilibrium diffusivity and the microscopic mechanisms by which cells stiffen and decelerate heterogeneously is crucial for a quantitative personalized diagnostic for hemostasis in SCD. 
